Understanding hereditary diseases using the dog and human as companion model systems

Mammalian Genome

Volumn 18, Issue 6-7, 2007, Pages 444-451

  Tsai, Kate L ^a   Clark, Leigh Anne ^a   Murphy, Keith E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA5; COLLAGEN TYPE 4 ALPHA6; DYSTROPHIN; OREXIN; UNCLASSIFIED DRUG;

ALPORT SYNDROME; DOG; EXON; GENE DELETION; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC TRANSCRIPTION; HEMOPHILIA B; HUMAN; KIDNEY DISEASE; MEDICAL RESEARCH; MISSENSE MUTATION; MUSCULAR DYSTROPHY; NARCOLEPSY; NONHUMAN; PATHOGENESIS; RETINA DEGENERATION; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; GENETIC DISEASES, INBORN; HEMOPHILIA B; HUMANS; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; NARCOLEPSY; NEPHRITIS, HEREDITARY; RETINAL DEGENERATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 34548391914     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-007-9037-1     Document Type: Review

References (87)

1. Acland GM, Ray K, Mellersh CS, Gu W, Langston AA, et al. (1998) Linkage analysis and comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology with retinitis pigmentosa (RP17) in humans. Proc Natl Acad Sci U S A 95:3048-3053
2. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, et al. (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28:92-95
3. Breen M, Hitte C, Lorentzen TD, Thomas R, Cadieu E, et al. (2004) An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics 5:65-75
4. Brooks MB, Gu W, Ray K (1997) Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B. J Am Vet Med Assoc 211:1418-1421
5. Brooks MB, Gu W, Barnas JL, Ray J, Ray K (2003) A line 1 insertion in the factor IX gene segregates with mild hemophilia in dogs. Mamm Genome 14:788-795
6. Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, et al. (2003) Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 10:750-757
7. Chase K, Lawler DF, Adler FR, Ostrander EA, Lark KG (2004) Bilaterally asymmetric effects of quantitative trait loci (QTLs): QTLs that affect laxity in the right versus left coxofemoral (hip) joints of the dog (Canis familiaris). Am J Med Genet 124A:239-247
8. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 98:437-451
9. Clark LA, Wahl JM, Steiner JM, Zhou W, Ji W, et al. (2005) Linkage analysis and gene expression profile of pancreatic acinar atrophy in the German Shepherd Dog. Mamm Genome 16:955-962
10. Cooper BJ, Winand NJ, Stedman H, Valentine VA, Hoffman EP, et al. (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334:154-156
11. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, et al. (1996) Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992
12. Cox ML, Lees GE, Kashtan CE, Murphy KE (2003) Genetic cause of X-linked Alport syndrome in a family of domestic dogs. Mamm Genome 14:396-403
13. Dauvilliers Y, Tafti M (2006) Molecular genetics and treatment of narcolepsy. Ann Med 38:252-262
14. Dauvilliers Y, Billiard M, Montplaisir J (2003) Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 114:2000-2017
15. Davidson AG, Bell RJ, Lee GE, Kashtan CE, Davidson GS, Murphy KE (2007) Genetic cause of autosomal recessive hereditary nephropathy in the English cocker spaniel. J Vet Intern Med 21:394-401
16. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322-327
17. Dell'Angola C, Wang Z, Storb R, Tapscott SJ, Kuher CS, et al. (2004) Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104:4311-4318
18. Evans JP, Watzke HH, Ware JL, Stafford DW, High KA (1989a) Molecular cloning of a cDNA encoding canine factor IX. Blood 74:207-212
19. Evans JP, Brinkhous KM, Brayer GD, Reisner HM, High KA (1989b) Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci U S A 86:10095-10099
20. Foster K, Foster H, Dickson JG (2006) Gene therapy progress and prospects: Duchenne muscular dystrophy. Gene Ther 13:1677-1685
21. Foutz AS, Mitler MM, Cavalli-Sforza LL, Dement WC (1979) Genetic factors in canine narcolepsy. Sleep 1:413-421
22. Goldstein O, Zangerl B, Pearce-Kelling SE, Sidjanin DJ, Kijas JW, et al. (2006) Linkage disequilibrium mapping in domestic dog breeds narrows the progressive rod-cone degeneration interval and identifies ancestral disease-transmitting chromosome. Genomics 88:541-550
23. Green PM, Giannelli F, Sommer SS, Poon M-C, Ludwig M, et al. (2004) The haemophilia B mutation database, ver. 13. Available at http://www.kcl.ac.uk/ip/ petergreen/intro.html
24. Gu W, Brooks M, Catalfamo J, Ray J, Ray K (1999) Two distinct mutations cause severe hemophilia B in two unrelated canine pedigrees. Thromb Haemost 82:1270-1275
25. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394
26. Guyon R, Lorentzen TD, Hitte C, Kim L, Cadieu E, et al. (2003) A 1-Mb resolution radiation hybrid map of the canine genome. Proc Natl Acad Sci U S A 100:5296-5301
27. Hartong DT, Berson EI, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795-1809
28. Harvey SJ, Zheng K, Jefferson B, Moak P, Sado Y, et al. (2003) Transfer of the α5(IV) collagen chain gene to smooth muscle restores in vivo expression of the α6(IV) collagen chain in a canine model of Alport syndrome. Am J Pathol 162:873-885
29. Heikkilä P, Tibell A, Morita T, Chen Y, Wu G, et al. (2001) Adenovirus-mediated transfer of type IV collagen α5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 8:882-890
30. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, et al. (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56-63
31. High KA (2004) Clinical gene transfer studies for hemophilia B. Semin Thromb Hemost 30:257-267
32. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928
33. Hood JC, Savige J, Hendtlass A, Kleppel MM, Huxtable CR, et al. (1995) Bull terrier hereditary nephritits: a model for autosomal dominant Alport syndrome. Kidney Int 47:758-765
34. Howell JM, Fletcher S, Kakulas BA, O'Hara M, Lochmuller H, et al. (1997) Use of the dog model for Duchenne muscular dystrophy in gene therapy. Neuromuscul Disord 7:325-328
35. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556
36. Hungs M, Fan J, Lin L, Lin X, Maki R, et al. (2006) Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Gen Res 11:531-539
37. Jacobson SG, Boye SL, Aleman TS, Conlon TJ, Zeiss CJ, et al. (2006) Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Hum Gene Ther 17:845-858
38. Jais JP, Knebelmann B, Giatras I, de Marchi M, Rizzoni G, et al. (2000) X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649-657
39. Jansen B, Thorner P, Baumal R, Valli V, Maxie MG, et al. (1986) Samoyed hereditary glomerulopathy (SHG). Evolution of splitting of glomerular capillary basement membranes. Am J Pathol 125:536-545
40. Juji T, Satake M, Honda Y, Doi Y (1984) HLA antigens in Japanese patients with narcolepsy. Tissue Antigen 24:316-319
41. Kashtan CE (1998) Disease of the month: Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9:1736-1750
42. Kashtan CE (2002) Animal models of Alport syndrome. Nephrol Dial Transplant 17:1359-1361
43. Kay MA, High K (1999) Gene therapy for the hemophilias. Proc Natl Acad Sci U S A 96:9973-9975
44. Kay MA, Rothenburg S, Landen CN, Bellinger DA, Leland F, et al. (1993) In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-119
45. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, et al. (1994) In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci U S A 91:2353-2357
46. Knebelmann B, Forestier L, Drouot L, Quinones S, Chuet C, et al. (1995) Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4:675-679
47. Knecht CD, Oliver JE, Redding R, Selcer R, Johnson G (1973) Narcolepsy in a dog and a cat. J Am Vet Med Assoc 162:1052-1053
48. Kornegay JN, Tuler SM, Miller DM, Levesque DC (1988) Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 11:1056-1064
49. Lees GE, Helman RG, Kashtan CE, Michael AF, Homco LD, et al. (1999) New form of X-linked dominant hereditary nephritis in dogs. Am J Vet Res 60:373-383
50. Lemmink HH, Mochizuki T, van den Heuvel LPWJ, Schroder CH, Barrientos A, et al. (1994) Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3:1269-1273
51. Lillicrap D, Vandenriessche T, High K (2006) Cellular and genetic therapies for haemophilia. Haemophilia 12:36-41
52. Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376
53. Lin L, Hungs M, Mignot E (2001) Narcolepsy and the HLA region. J Neuroimmunol 117:9-20
54. Lindblad-Toh K (2006) Trait mapping using a canine SNP array. In Proceedings of the 3rd International Conference on Advances in Canine and Feline Genomics. Davis, CA, 2-5 August 2006
55. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al. (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803-819
56. Maret S, Tafti M (2005) Genetics of narcolepsy and other major sleep disorders. Swiss Med Wkly 135:662-665
57. Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, et al. (1998) High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9:2291-2301
58. Mauser AE, Whitlark J, Whitney KM, Lothrop CD (1996) A deletion mutation causes hemophilia B in Lhasa Apso dogs. Blood 88:3451-3455
59. McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD (2006) Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther 13:1373-1381
60. Mignot E (1998) Genetic and familial aspects of narcolepsy. Neurol 50(Suppl 1):S16-S22
61. Mignot E (2004) Sleep, sleep disorders and hypocretin (orexin). Sleep Med 5(Suppl 1):S2-S8
62. Miner JH, Sanes JR (1996) Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J Cell Biol 135:1403-1413
63. Mochizuki T, Lemmink HH, Mariyama M, Antignas C, Gubler MC, et al. (1994) Identification of mutations in the alpha-3(IV) and alpha-4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-82
64. Mount JD, Herzog RW, Tillson DM, Goodman SA, Robinson N, et al. (2002) Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 99:2670-2676
65. Nishino S, Arrigoni J, Shelton J, Kanbayashi T, Dement WC, Mignot E (1997) Affects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. J Neurosci 17:6401-6408
66. Nishino S, Reid MS, Dement WC, Mignot E (1994) Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 17:S84-S92
67. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40
68. Online Mendelian Inheritance in Animals, OMIA. Reprogen, Faculty of Veterinary Science, University of Sydney and Australian National Genomic Information Service (ANGIS), University of Sydney, January 2007. Available at: http://www.omia.angis.org.au/
69. Ostrander EA, Giniger E (1997) Semper fidelis: What man's best friend can teach us about human biology and disease. Am J Hum Genet 61:475-80
70. Ostrander EA, Galibert F, Patterson DF (2000) Canine genetics comes of age. Trends Genet 16:117-124
71. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997
72. Rheault MN, Kren SM, Thielen BK, Mesa HA, Crosson JT, et al. (2004) Mouse model of X-linked Alport Syndrome. J Am Soc Nephrol 15:1466-1474
73. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585
74. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, et al. (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574-579
75. Seignalet J, Billiard M (1984) Possible association between HLA-B7 in narcolepsy. Tissue Antigens 23:188-189
76. Sharp NJH, Kornegay JN, Van Camp SD, Herbstrieth MH, Secore SL, et al. (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13:115-121
77. Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, et al. (1999) Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5:64-70
78. Sutter NB, Bustamante CD, Chase K, Gray MM, Zhao K, et al. (2007) A single IGF1 allele is a major determinant of small size in dogs. Science 316:112-115
79. Tanabe Y, Esaki K, Nomura T (1986) Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 69:91-95
80. Todhunter RJ, Acland GM, Olivier M, Williams AJ, Vernier-Singer M, et al. (1999) An outcrossed canine pedigree for linkage analysis of hip dysplasia. J Hered 90:83-92
81. Tsai KL, Murphy KE (2006) clinical and genetic assessments of hip joint laxity in the Boykin Spaniel. Can J Vet Res 70:148-150
82. Tryggvason K, Martin P (2001) Alport syndrome and basement membrane collagen. In: The Metabolic and Molecular Basis of Inherited Disease, Schriver CR, Beaudet AL, Sly WS, Valle D, Childs B, et al. (eds.) (Philadelphia: McGraw-Hill), chap 214, pp 5453-5466
83. Wagner JL, Storb R, Storer B, Mignot E (2000) DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs. Tissue Antigens 56:223-231
84. Wang L, Nichols TC, Read MS, Bellinger DA, Verma IM (2000) Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther 1:154-158
85. Zangerl B, Sun Q, Pillardy J, Johnson JL, Schweitzer PA, et al. (2006a) Development and characterization of a normalized canine retinal cDNA library for genomic and expression studies. Invest Opthalmol Vis Sci 47:2632-2638
86. Zangerl B, Goldstein O, Philp AR, Lindauer SJP, Pearce-Kelling SE, et al. (2006b) Identical mutation in a novel retinal gene causes progressive rod-cone degeneration in dogs and retinitis pigmentosa in humans. Genomics 88:551-563
87. Zheng K, Thorner PS, Marrano P, Baumal R, McInnes RR (1994) Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc Natl Acad Sci U S A 91:3989-3993